| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb0d5481ad019c6300fe430e580aaeef |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-48707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B33Y80-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-08 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14532
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-14865 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2004-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f84dd552306ef32fa1911f0532ce6d46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5dfb5b1b256a2eb26a46e6e1d69bdc2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8228d7fc36bb171eaf468805363d59c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb1798441ac11e1810890be6a79a91cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eb427aad67891598be59a847e42d881 |
| publicationDate |
2011-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1624908-B8 |
| titleOfInvention |
Biointerface membranes incorporating bioactive agents |
| abstract |
A biointerface membrane (30) for an implantable device including a nonresorbable solid portion (36) with a plurality of interconnected cavities (38) therein adapted to support tissue ingrowth in vivo, and a bioactive agent incorporated into the biointerface membrane and adapted to modify the tissue response is provided. The bioactive agents can be chosen to induce vascularization and/or prevent barrier cell layer formation in vivo, and are advantageous when used with implantable devices wherein solutes are transported across the device-tissue interface (42). |
| priorityDate |
2003-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |